Recombinant WNV NS1 Protein, His-tagged

• Cat.No.: WES-623
• Product Overview: West Nile Virus NS1 protein is produced entirely from human cell lines using state-of-the-art expression techniques, the same approach which NAC used to develop its well received DENV NS1 (4 serotypes) and YFV NS1 proteins.

Specification

• Tag: His
• Background: The West Nile Virus (WNV) NS1 protein is a native hexameric presentation. The hexamer is believed to be the biologically active form of NS1 involved in key aspects of West Nile Fever pathogenesis (Kaiser et al., 2017). The resultant WNV NS1 protein is purified to a high degree, is in its native folding state, and possesses all post-translational modifications. This advanced approach results in a product which delivers optimal antigenicity by virtue of its human origin
  The West Nile Virus NS1 Protein has been manufactured in response to the unmet need for a highly purified, concentrated protein for use in further vaccine development and serological based diagnostic assays. The detection of the NS1 protein offers much higher fidelity across multiple flaviviruses where cross-reactivity can otherwise pose an issue.
• Purity: >95%
• Sequence Strain: NY99
• Formulation: DPBS pH 7.4, 0.2μm filter sterilised.
• Stability: Stable for 1 year at +4 centigrade; stable for 1 year at <-20 centigrade
• Freezing: Can be frozen
• Storage: Short Term Storage: +4 centigrade
  Long Term Storage: -80 centigrade
  Multiple freeze/thaw cycles are to be avoided.
• Concentration: mg/mL (Specification: 0.4 – 1.0 mg/mL by BCA assay)
• Notes: This product is intended for research and manufacturing uses only. It is not a diagnostic device. The user assumes all responsibility for care, custody and control of the material, including its disposal, in accordance with all regulations.
• Type: Recombinant
• ClassID 1: Infectious Disease

Gene Information

• Synonyms: West Nile Virus NS1